MetS
DHA supplementation
impact of EPA
anti-inflammatory effects of EPA
molecular studies
anti-inflammatory molecular mechanisms of EPA
adipose tissue-specific subclinical inflammation
PUFA
plasma
previous studies
comprehensive studies
fatty acid supplementation
prevalent causes of subclinical inflammation
Mechanistic studies of long chain omega
dietary long chain omega
docosahexaenoic acid
eicosapentaenoic acid
kinetics of inflammatory biomarkers
similar effects
pro-inflammatory processes
women
pro-inflammatory state
metabolic syndrome
molecular targets
different LCn
efficacy of LCn
proposed research
use of specific dietary treatment modalities
innovative kinetics
role of lipid mediators specific
systemic levels
polyunsaturated fatty acids
possible gender differences
crossover randomized placebo-controlled study
health professionals
humans
key factor
potential prevention strategies
needed evidence-based justification
policy makers
stable isotopes
oxygenated derivatives
growing body of literature
lifestyle-related
date
development of cardiovascular diseases
markers of oxidative stress
in-depth understanding
quantifying
sex
Obesity
data
mixture
objective